This compound is a nitrosamine impurity associated with the pharmaceutical compound sitagliptin. It is primarily recognized as a process-related impurity in pharmaceutical manufacturing and quality control.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2892260-32-9
2-Amino-4'-chlorobenzophenone
pharmaceutical intermediate
8-benzyl-8-azabicyclo[3.2.1]octan-3-one
pharmaceutical intermediate for tropane derivatives
2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoic acid
Pharmaceutical intermediate for netupitant synthesis
L-Methionine ethyl ester hydrochloride
Pharmaceutical intermediate
3-(TRIFLUOROMETHYL)-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE
Pharmaceutical intermediate for sitagliptin
3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
Pharmaceutical intermediate
7-nitroso-3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine
HPLUAAVIJHAQQZ-UHFFFAOYSA-N
C1CN2C(=NN=C2C(F)(F)F)CN1N=O